The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

26 Jul 2011 13:01

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are Scancell Holdings plc attached:ii 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the Calculus Capital Limitednotification obligation:iii 4. Full name of shareholder(s) HSBC Global Custody (UK) Limited (if different from 3.):iv 5. Date of the transaction and date on which the threshold is crossed or 26 July 2011reached: v 6. Date on which issuer notified: 26 July 2011 7. Threshold(s) that is/are crossed or 10,11,12,13%reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction Number Number Number Number of voting % of voting rightsif possible of of of shares rights x using Shares Voting the ISIN Rights Direct Direct xi Indirect Direct Indirect CODE xii Ordinary Shares ISIN: 15,277,780 15,277,780 25,277,780 25,277,780 13.02 % GB00B39J5N63 B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting % of voting financial date xiii Conversion Period xiv rights that may be rights instrument acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of Exercise price Expiration Exercise/ Number of voting % of voting financial date xvii Conversion rights instrument rights xix, xx instrument period refers to xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 25,277,780 13.02 %

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

N/A Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease N/Ato hold: 12. Date on which proxy holder will cease to hold N/Avoting rights: 13. Additional information: N/A 14. Contact name: Calculus Capital Limited 15. Contact telephone number: 0207 493 4940

Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii A: Identity of the persons or legal entity subject to the notification obligation Full name (including legal form of legal entities) Contact address (registered office for legal entities) Phone number & email Other useful information (at least legal representative for legal persons)

B: Identity of the notifier, if applicable Full name Contact address Phone number & email Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

XLON
Date   Source Headline
29th Oct 20217:00 amRNSResults for the year ended 30 April 2021
28th Oct 202111:23 amRNSExtension of CLN Redemption Dates
19th Oct 20217:00 amRNSNew facilities at The Oxford Science Park
15th Oct 20217:00 amRNSNotice of Final Results
5th Oct 20214:22 pmRNSFirst subject dosed in COVIDITY clinical trial
9th Sep 20214:31 pmRNSPDMR dealing
26th Aug 20217:00 amRNSModi-1 Phase I/II CTA approved by MHRA
17th Aug 20217:00 amRNSScancell selects PharmaJet’s Needle-free Systems
30th Jul 20219:52 amRNSDirector Dealing
29th Jul 20217:00 amRNSCOVIDITY Phase 1 trial application in SA approved
28th Jul 20215:00 pmRNSLindy Durrant appointed CEO of Scancell
22nd Jun 20217:00 amRNSCOVIDITY trial planned in South Africa and UK
15th Jun 20217:00 amRNSAppointment of Joint Broker
8th Jun 20214:41 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
7th Jun 20218:49 amRNSDirector Dealing
30th Apr 202110:48 amRNSDirector Dealing
10th Mar 20219:58 amRNSHolding(s) in Company
2nd Mar 20214:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:00 pmRNSDirector Dealing
19th Feb 20217:00 amRNSDirector Dealing
17th Feb 20212:04 pmRNSDirector Dealing
16th Feb 20213:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
15th Feb 20213:36 pmRNSStatement regarding share price movement
15th Feb 202111:05 amRNSSecond Price Monitoring Extn
15th Feb 202111:00 amRNSPrice Monitoring Extension
15th Feb 20219:05 amRNSSecond Price Monitoring Extn
15th Feb 20219:00 amRNSPrice Monitoring Extension
3rd Feb 20217:00 amRNSUpdate on SCIB2 clinical development partnership
29th Jan 20217:00 amRNSInterim Results for the 6 months ended 31 Oct 2020
30th Dec 20202:00 pmRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
18th Dec 20202:05 pmRNSSecond Price Monitoring Extn
18th Dec 20202:00 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSCOVID-19 vaccine candidate selected
15th Dec 20203:45 pmRNSDirector Dealing
14th Dec 20201:03 pmRNSDirector Dealing
25th Nov 202011:26 amRNSDirector Dealing
17th Nov 20202:34 pmRNSResults of Annual General Meeting
17th Nov 202012:00 pmRNSAppointment of CMO and Medical Director
13th Nov 202012:36 pmRNSDirector Dealing
10th Nov 20202:44 pmRNSDirector Dealing
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:01 pmRNSPrice Monitoring Extension
6th Nov 202011:49 amRNSHolding(s) in Company
5th Nov 202010:51 amRNSResult of Adjourned General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.